BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7926495)

  • 1. A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group.
    Smith PM; Kerr GD; Cockel R; Ross BA; Bate CM; Brown P; Dronfield MW; Green JR; Hislop WS; Theodossi A
    Gastroenterology; 1994 Nov; 107(5):1312-8. PubMed ID: 7926495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
    Swarbrick ET; Gough AL; Foster CS; Christian J; Garrett AD; Langworthy CH
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):431-8. PubMed ID: 8804870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-utility analysis comparing omeprazole with ranitidine in the maintenance therapy of peptic esophageal stricture.
    Stal JM; Gregor JC; Preiksaitis HG; Reynolds RP
    Can J Gastroenterol; 1998; 12(1):43-9. PubMed ID: 9544411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
    Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH
    J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis.
    Silvis SE; Farahmand M; Johnson JA; Ansel HJ; Ho SB
    Gastrointest Endosc; 1996 Mar; 43(3):216-21. PubMed ID: 8857137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
    Dent J; Yeomans ND; Mackinnon M; Reed W; Narielvala FM; Hetzel DJ; Solcia E; Shearman DJ
    Gut; 1994 May; 35(5):590-8. PubMed ID: 8200548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
    Hallerbäck B; Unge P; Carling L; Edwin B; Glise H; Havu N; Lyrenäs E; Lundberg K
    Gastroenterology; 1994 Nov; 107(5):1305-11. PubMed ID: 7926494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
    Venables TL; Newland RD; Patel AC; Hole J; Wilcock C; Turbitt ML
    Scand J Gastroenterol; 1997 Oct; 32(10):965-73. PubMed ID: 9361167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine.
    McFarland RJ; Bateson MC; Green JR; O'Donoghue DP; Dronfield MW; Keeling PW; Burke GJ; Dickinson RJ; Shreeve DR; Peers EM
    Gastroenterology; 1990 Feb; 98(2):278-83. PubMed ID: 2403952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease.
    Revicki DA; Sorensen S; Maton PN; Orlando RC
    Dig Dis; 1998; 16(5):284-91. PubMed ID: 9892788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
    Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
    Stålhammar NO; Carlsson J; Peacock R; Müller-Lissner S; Bigard MA; Porro GB; Ponce J; Hosie J; Scott M; Weir DG; Fulton C; Gillon K; Bardhan KD
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):483-97. PubMed ID: 10662395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological aspects and healing rates of gastric ulcers treated with omeprazole 20 mg once daily or ranitidine 150 mg B.I.D.
    Rossini FP; Spandre M; Gemme C; Cavallero M; Bertone A; Coverlizza S; Risio M
    Panminerva Med; 1989; 31(2):94-6. PubMed ID: 2797847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.
    Marks RD; Richter JE; Rizzo J; Koehler RE; Spenney JG; Mills TP; Champion G
    Gastroenterology; 1994 Apr; 106(4):907-15. PubMed ID: 7848395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole and ranitidine in the prevention of relapse in patients with duodenal ulcer disease.
    Lauritsen K; Rutgersson K; Bolling E; Brunner G; Eriksson S; Galmiche JP; Walan A; Archambault AP; Gudjónsson H; Bailey RJ; Bianchi Porro G; Frison L; Havu N; Thompson AB
    Can J Gastroenterol; 1999 Dec; 13(10):806-13. PubMed ID: 10625320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
    Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB
    Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
    Walan A; Bader JP; Classen M; Lamers CB; Piper DW; Rutgersson K; Eriksson S
    N Engl J Med; 1989 Jan; 320(2):69-75. PubMed ID: 2643037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L; Backman L; Ekström P; Enander LK; Falkmer S; Fausa O; Grimelius L; Havu N; Lind T; Lönroth H
    Scand J Gastroenterol; 1991 Mar; 26(3):248-56. PubMed ID: 1853146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.